Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NANP | Q8TBE9 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12015063 | 0.90 | L3MBTL1 (0.54) | L3MBTL1NANP | |
| SCHEMBL12731860 | 0.90 | L3MBTL1 (0.54) | L3MBTL1NANP | |
| SCHEMBL14648888 | 0.90 | L3MBTL1 (0.54) | L3MBTL1NANP | |
| SCHEMBL15471527 | 0.90 | L3MBTL1 (0.54) | L3MBTL1NANP | |
| SCHEMBL16272856 | 0.90 | L3MBTL1 (0.54) | L3MBTL1NANP | |
| SCHEMBL12302605 | 0.90 | L3MBTL1 (0.54) | L3MBTL1NANP | |
| SCHEMBL15119381 | 0.85 | L3MBTL1 (0.57) | L3MBTL1NANP | |
| SCHEMBL14780771 | 0.84 | NANP (0.53) | L3MBTL1NANP | |
| SCHEMBL15143127 | 0.80 | L3MBTL1 (0.44) | L3MBTL1NANP | |
| SCHEMBL8905452 | 0.78 | L3MBTL1 (0.55) | L3MBTL1NANP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | ASNS, BSG, ANPEP | L3MBTL1 2569/4885NANP 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.